|
|
Volumn 19, Issue 4, 2007, Pages 234-236
|
|
UK National Colorectal Cancer Consensus Meeting 2006
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CETUXIMAB;
FLUOROPYRIMIDINE DERIVATIVE;
FLUOROURACIL;
FOLINIC ACID;
NEW DRUG;
OXALIPLATIN;
ADJUVANT THERAPY;
CANCER ADJUVANT THERAPY;
CANCER RECURRENCE;
CANCER SCREENING;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL DECISION MAKING;
CLINICAL TRIAL;
COLORECTAL CANCER;
DRUG APPROVAL;
DRUG COST;
EARLY DIAGNOSIS;
EDITORIAL;
HEALTH CARE COST;
HEALTH CARE QUALITY;
HEALTH PROGRAM;
HUMAN;
INTESTINE CANCER;
JOB SATISFACTION;
JOB STRESS;
LOW DRUG DOSE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OCCULT BLOOD;
PATIENT EDUCATION;
PATIENT REFERRAL;
PRACTICE GUIDELINE;
PREOPERATIVE EVALUATION;
PRIMARY MEDICAL CARE;
PRIORITY JOURNAL;
PROGNOSIS;
RECTUM CANCER;
RECURRENCE RISK;
STRESS MANAGEMENT;
UNITED KINGDOM;
COLORECTAL NEOPLASMS;
GREAT BRITAIN;
HUMANS;
MASS SCREENING;
STATE MEDICINE;
|
|
EID: 34047251859
PISSN: 09366555
EISSN: None
Source Type: Journal
DOI: 10.1016/j.clon.2007.02.014 Document Type: Editorial |
|
Times cited : (3)
|
|
References (0)
|
